Company Overview
| Stock Name | Hospital Corp |
|---|---|
| Stock Code | 03869 |
| Company Full Name | To be extracted |
| Industry | Healthcare |
| Principal Activities | 我們是由具有豐富醫院管理經驗的專業團隊領導的醫院運營管理集團,通過運營與管理醫院,整合旗下醫院所在區域內的醫療資源,構建區域醫療服務中心,專注於常見病、多發病及慢性病診療,並擁有及經營綜合醫院。 |
| Listing Date | 2017-03-16 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國北京市海淀區知春路6號錦秋國際大廈B座1602室 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | hcclhealthcare.com |
| Share Registrar | 香港中央證券登記有限公司 (Computershare Hong Kong Investor Services Limited) |
| Registrar Contact | (852)2862 8628 |
| A-Share/US Dual Listing | No |
Offering Information
| Offering Mechanism | Mechanism A |
|---|---|
| Offer Price | HK$ 12.80 / shares |
| Offer Price Range | To be extracted |
| Lot Size | 200 shares |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | 2017-02-28 to 2017-03-09 |
| Global Offering Shares | 33,334,000 shares |
| HK Public Offer Shares (Initial) | 3,333,600 shares (10.0%) |
| Public Offer Lots (Initial) | 16,668lots (Pool A8,334lots,Pool B8,334lots) |
| International Placing Shares (Initial) | 30,000,400 shares (90.0%) |
| Offer Ratio | ~10.0% |
| Total Shares Post-IPO | 133,194,000 shares |
| Greenshoe (Over-allotment Option) | Yes |
| Stabilizing Manager (Greenshoe) | To be extracted |
| Cornerstone Share | 6.8% |
| Clawback Tiers | To be extracted |
| Reallocation Option | Yes |
| Total Global Offering Size | HK$ 426,675,200 |
Stock Connect Inclusion Analysis
| 26Q4 Regular Review | |
| Inclusion Pathway | Regular Path |
|---|---|
| Avg Daily HK Mkt Cap | HK$ 447.4M |
| Est. Threshold | HK$ 9.71B |
| Analysis Result | HK market cap below threshold, need +2071% |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | Not disclosed |
| P/E Ratio | Not disclosed |
| Profit/Loss Status | 盈利約人民幣67.3百萬元 |
| Period-End Cash Balance | 人民幣13.1百萬元 |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
Financial Data
Unit:
'000
RMB
Income Statement
| Item | 2013 | 2014 | 2015 | 2016-09 |
|---|---|---|---|---|
| Revenue | 46,443 | 80,409 | 89,234 | 63,807 |
| Cost of sales | -6,170 | -23,166 | -32,831 | -35,160 |
| Gross profit | 40,273 | 57,243 | 56,403 | 28,647 |
| Other income and gains, net | 54 | 137 | 2,477 | 57 |
| Selling and distribution expenses | 0 | -18 | -1 | -3 |
| Administrative expenses | -1,238 | -2,848 | -3,755 | -3,196 |
| Operating profit | 39,089 | 54,443 | 55,013 | 25,526 |
| Profit before tax | 39,118 | 55,610 | 55,066 | 25,582 |
| Income tax expense | -10,029 | -14,565 | -13,772 | -7,816 |
| Profit for the year | 29,089 | 41,045 | 41,294 | 17,766 |
| Profit attributable to owners | 29,089 | 41,045 | 41,294 | 17,766 |
Balance Sheet
| Item | 2013 | 2014 | 2015 | 2016-09 |
|---|---|---|---|---|
| Cash and cash equivalents | 9,020 | 5,134 | 13,086 | 56,854 |
| Trade and bills receivables | 0 | 1,563 | 7,490 | 6,588 |
| Inventories | 0 | 851 | 1,180 | 1,961 |
| Total current assets | 43,735 | 168,648 | 132,609 | 85,117 |
| Total assets | 64,821 | 207,750 | 172,070 | 124,915 |
| Total current liabilities | 24,164 | 176,498 | 99,724 | 58,436 |
| Total liabilities | 24,164 | 179,048 | 102,074 | 60,636 |
| Total equity | 40,657 | 28,702 | 69,996 | 64,279 |
| Equity attributable to owners | 40,657 | 28,702 | 69,996 | 64,279 |
Cash Flow Statement
| Item | 2013 | 2014-09 | 2014 | 2015-09 | 2015 | 2016-09 |
|---|---|---|---|---|---|---|
| Net cash from operating activities | 9,386 | 19,491 | 7,331 | 104,282 | ||
| Net cash from investing activities | -716 | -103,377 | 80,621 | -7,514 | ||
| Net cash from financing activities | 0 | 80,000 | -80,000 | -53,000 | ||
| Net increase in cash | 8,670 | -3,886 | 7,952 | 43,768 | ||
| Purchase of PP&E | -716 | -5,259 | -5,834 | -976 | -1,168 | -7,514 |
Income Statement
Balance Sheet
Cash Flow Statement
Source: Accountants' Report and Audited Consolidated Financial Statements
| First Day Close | HK$ 12.96 |
|---|---|
| First Day Open | HK$ 13.0 |
| First Day Change | 1.25% |
| First Day Volume | 7777800.0 |
| First Day Turnover | 99297800.0 |
| Use of Proceeds | 1、171.8百萬港元(50%)將用于戰略性收購位于中國的醫院;
2、61.8百萬港元(18%)將不時用于對我們所擁有或管理的醫院(非營利性醫院除外)進一步投資;
3、51.5百萬港元(15%)將用于醫院及我們不時擁有或管理的其他醫院的雇員培訓計劃、人才引進及學術研究活動;
4、24.1百萬港元(7%)將用于升級及改良我們的信息技術系統;
5、34.5百萬港元(10%)將用于為我們的營運資金、租金和物業相關開支及其他一般企業用途提供資金。 |
Underwriting Syndicate
Sole Sponsor (1)
CHINA INTERNATIONAL CAPITAL CORPORATION HONG KONG SECURITIES LIMITED CE AEN894
Overall Coordinators (1)
CHINA INTERNATIONAL CAPITAL CORPORATION HONG KONG SECURITIES LIMITED CE AEN894
Joint Bookrunners (1)
CHINA INTERNATIONAL CAPITAL CORPORATION HONG KONG SECURITIES LIMITED CE AEN894
Joint Lead Managers (1)
CHINA INTERNATIONAL CAPITAL CORPORATION HONG KONG SECURITIES LIMITED CE AEN894
Cornerstone Investors
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
|---|---|---|---|---|---|---|---|
| 1 | 安徽省中安健康养老服务 | 116,464,640 HKD | — | 6.80% | — | 6 months | 2017-09-16 |
Directors & Management
| Position | Chinese name | English Name |
|---|---|---|
| Chairman | 趙令歡 | — |
| Company Secretary | 鄺燕萍 | — |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | Vanguard Glory及弘毅投資實體為控股股東,緊接全球發售前持有已發行股本97.14%權益;緊隨全球發售完成後(假設超額配股權未獲行使)持有約72.83%權益。 |
|---|




